LYON, France & NEW YORK--(BUSINESS WIRE)--The MEDICREA Group (Paris:ALMED) (Alternext Paris: FR0004178572 - ALMED), PEA-PME eligible, which specializes in the development and manufacturing of innovative surgical technologies for the treatment of spinal pathologies, announces its audited 2014 annual results (IFRS based), approved by the Board meeting of April the 2nd.
Help employers find you! Check out all the jobs and post your resume.
